Navigation Links
AMDL Teleconference Available on amdl.com at 5:00 p.m. EDT Today
Date:5/22/2008

TUSTIN, Calif., May 22 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), (http://www.amdl.com ), a world leader in specialty pharmaceuticals with operations in Shenzhen, Jiangxi and Jilin, China, announced today that it has made available the AMDL executive management comments from its Q1 2008 financial results conference call. The document can be accessed via AMDL's corporate website at http://www.amdl.com. Click on "Investor Relations" then "Recent News."

The posted conference call script outlines prepared remarks AMDL's executive management made covering the Company's financial results for the first quarter of FY2008 and the subsequent question and answers from shareholders.
Highlighted comments from AMDL's CEO Gary Dreher included:

-- We have responded to the U.S. FDA regarding requests for information on

our DR-70(TM) cancer test within the time period required;

-- AMDL's executive management team is committed to increasing shareholder

communications, including formally issuing corporate guidance;

-- We are focused on growing annual sales at a minimum rate of 100 percent

over the next three years.

-- 2007 sales were $15 million and we are on track to at least doubling

sales in 2008;

-- AMDL will leverage its land holdings in China (estimated to be worth

between $15-$21 million) to gain a new credit facility in place by Q3,

2008.

-- We plan to finance continued growth with debt and credit lines. We do

not plan to pursue the same type of 25 percent discounted equity

funding as we've done in previous rounds;

-- AMDL's anti-aging Goodnak product line is enjoying high growth demand

and we anticipate it will be exported to the US and Europe in the

future;

-- AMDL's head of R&D Dr. Andrea Small-Howard has concluded that the HPV

Test Kit licensed by the Company for distribution in China, Hong Kong,

Taiwan, Singapore, Malaysia, Thailand, Cambodia and Vietnam has

numerous advantages over other test kits for HPV and can become a major

product for the Company.

About AMDL:

AMDL, Inc. is a global specialty pharmaceutical company. The company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The company employs approximately 320 people in the U.S. and China. More information about AMDL and its products can be obtained at http://www.amdl.com .

About Jade Pharmaceutical:

JPI has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiaries, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

IR Contact: Mr. Paul Knopick

Direct: 949.707.5365

Voicemail: 714.505.4460


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
2. HMS Holdings Corp. Hosts Third Quarter 2007 Financial Teleconference and Presentation
3. Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
4. Onyx Pharmaceuticals Announces Third Quarter 2007 Financial Results Teleconference and Webcast
5. Vermillion to Host Teleconference and Webcast to Discuss Third Quarter 2007 Financial Results on November 12 at 4:30 pm Eastern Time
6. World AIDS Day Teleconference for Media, Including Helen Epstein, Author of the Invisible Cure, and Beatrice Were, Ugandan Womens Rights Advocate
7. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
8. Interactive Teleconference on Inflammatory Bowel Disease for Patients, Caregivers, and Healthcare Professionals
9. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
10. Progen Investor Teleconference Dial In Details
11. HMS Holdings Corp. Hosts Fourth Quarter and Full Year 2007 Financial Teleconference and Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: